SANUWAVE Health Inc at LD Micro Main Event Transcript

Dec 14, 2020 / 03:00PM GMT
Operator

All right, everyone. Welcome this morning. I am with Kevin Richardson, all right. And he is with SANUWAVE Health. They are a medical technology company focused on the development and commercialization of its proprietary FDA-cleared system for use in regenerative medicine and wound care. In August 2020, the company acquired Celularity, Inc.'s UltraMIST, ultrasound therapy device and partnership rights for Wound Care Biologic products.

Take it away, Kevin.

Kevin Richardson - SANUWAVE Health, Inc. - CEO & Chairman of the Board of Directors

Okay. Thank you very much. My name is Kevin Richardson. I'm the CEO and Chairman of SANUWAVE Health. We're a Wound Care Solutions company. I'll be spending the next 10 minutes talking about our portfolio, our go-to-market strategy and why we represent an interesting investment opportunity in ways that we can help heal today and cure tomorrow.

Let me first start with the forward-looking statement. Please review this, if you have time. It is obligatory that we have to say. Great.

So the company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot